You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 528 Activated T cells engage IL-1 and TNFa-driven tumor inflammation to support immune checkpoint inhibitor resistance in inflammatory solid malignancies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
528 Activated T cells engage IL-1 and TNFa-driven tumor inflammation to support immune checkpoint inhibitor resistance in inflammatory solid malignancies

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023148011
Dec 20236307
Jan 20243806
Feb 20245403
Mar 20242002
Apr 20246004
May 2024601
Jun 20241401
Jul 20241402
Aug 20241001
Sep 20243303
Oct 20242809
Nov 20241603
Dec 20243207
Jan 20251906
Feb 2025402
Mar 2025003
Apr 2025001
May 2025002
Jun 2025002
Total559076